AT a time when germs are growing more resistant to common antibiotics, many companies that are developing new versions of the drugs are hemorrhaging money and going out of business, gravely...

[BEIJING] Drugmakers including AstraZeneca and Roche Holding agreed to cut prices of some of their newest innovative drugs in China by an average of 61 per cent as the government expanded the...

[LONDON] Pharma companies ramped up their stockpiles of drugs to prepare for a potentially chaotic Brexit. Now they're in the dark about how long they'll need to hold them.

[WASHINGTON] The pharmaceutical industry's leading trade group disclosed on Tuesday that it had spent a record US$27.5 million on lobbying in 2018, US$1.4 million more than in 2009, when Congress...

[HONG KONG] There may be such a thing as a free lunch in China's pharmaceutical industry. It turns out it's not an unlimited buffet, though.

[NEW YORK] Novartis AG and Bayer AG are among nearly 30 drugmakers that have taken steps to raise the US prices of their medicines in January, ending a self-declared halt to increases made by a...